Entelexo Biotherapeutics
Creating a New Class of Drugs to Address Incurable Autoimmune Diseases
Biotech
About
Entelexo is creating modern treatments for immune-mediated diseases, such as psoriasis, using novel engineered exosome technology.
Build your own investing agent
GPAgent keeps YC listings public and neutral. Fund-specific scoring, notes, and workflow state live in each customer workspace.
Join the GPAgent waitlistDetails
Status
Active
Stage
Early
Team Size
3
Regions
United States of America, America / Canada